Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 1999

View Archived Issues

Amarillo's fibromyalgia trial expanded

Natural insulin-sensitizing agent may help cure PCOS infertility

Oxigene: Annual Report 1998/Q1 1999 highlights

Company Profile: Nanosyn

Sublingual apomorphine aids in erectile dysfunction

Lilly: Annual Report 1998

Neurocrine Biosciences: Q1 1999 highlights

Yamanouchi describes novel series of factor Xa inhibitors

IND exemption granted to Polydex's STD/contraceptive drug

Potent, orally active antiulcer agents synthesized at SS Pharm.

Sankyo's new antibiotics described in patent literature

New antiinflammatory/analgesic agents with both topical and oral activity

Telmisartan now available in Spanish pharmacies

Naturally occurring terpene with immunosuppressive and neovascularization-inhibitory effects

NA-00226B and C, produced by Streptomyces, inhibit cAMP PDE activity

Licensing opportunity from NIH: recombinant antitumor RNases

HCV antisense oligonucleotide reduces HCV gene expression in mouse model

Progenics: Q1 1999 highlights

Licensing opportunity from NIH: BChE inhibitors for Alzheimer's disease Rx, Dx

Phase I trial results reported for GA-EPO at nephrology congress

AVI BioPharma: Q1 1999 highlights

KH-1060: immunomodulating effects studied in mouse skin graft model

LU-135252 used to investigate role of ETA receptor in cardiac hypertrophy

Beneficial effects of TAK-044 in kidney autotransplanted dogs

PST-2238: novel antihypertensive agent targeting ouabain

Structural Bioinformatics develops antagonists of BcL-2 gene product

Flixotide submitted for COPD in major markets

Single-isomer valproic acid patented in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026